US Patent Issued to SHANGHAI CUREGENE PHARMACEUTICAL on Sept. 9 for "Antiplatelet drugs and uses thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,132, issued on Sept. 9, was assigned to SHANGHAI CUREGENE PHARMACEUTICAL Co. LTD. (Shanghai).

"Antiplatelet drugs and uses thereof" was invented by Zi-Qiang Gu (Reston, Va.), Yuanchao Zhang (Fulton, Md.), Gongxin He (Shanghai), Kai Hou (Shanghai) and Hao Wu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds which exhibit activity in the inhibition of platelet aggregation as well as pharmaceutical compositions comprising these compounds and methods of treatment of vascular diseases by administration of these compounds or the pharmaceutical compositions."

The patent was filed on July 28, 2021, under ...